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Abstract  
Chemoprevention by isothiocyanates from cruciferous vegetables occurs partly 
through up-regulation of phase-II conjugating enzymes, such as UDP-glucuronosyl-
transferases (UGT).  UGT1A1 glucuronidates bilirubin, estrogens, and several dietary 
carcinogens.  The UGT1A1*28 polymorphism reduces transcription compared to the 
wild-type, resulting in decreased enzyme activity.  Isothiocyanates are metabolized by 
glutathione-S-transferases (GST); variants may alter isothiocyanate clearance, such that 
response to crucifers may vary by genotype.  We evaluated, in a randomized, controlled, 
cross-over feeding trial in humans (n=70), 3 test diets, (single- and double-“dose” 
cruciferous and cruciferous plus apiaceous) compared to a fruit-and-vegetable-free basal 
diet.  We measured serum bilirubin concentrations on days 0, 7, 11 and 14 of each 2-
week feeding period to monitor UGT1A1 activity, and determined effects of UGT1A1*28 
and GSTM1/GSTT1-null variants on response.  Aggregate bilirubin response to all 
vegetable-containing diets was statistically significantly lower compared to the basal diet 
(p<0.03 for all).  Within each UGT1A1 genotype, lower bilirubin concentrations were 
seen in: *1/*1 in both single and double-dose cruciferous diets compared to basal (p<0.03 
for both); *1/*28 in double-dose cruciferous and cruciferous plus apiaceous compared to 
basal, and cruciferous plus apiaceous compared to single-dose cruciferous (p<0.02 for 
all); and *28/*28 in all vegetable-containing diets compared to basal (p<0.02 for all).  
Evaluation of the effects of diet stratified by GST genotype revealed some statistically 
significant genotypic differences however, the magnitude was similar and not statistically 
significant between genotypes.  These results may have implications for altering 
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carcinogen metabolism through dietary intervention, particularly among UGT1A1*28/*28 
individuals. 
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Introduction 
Consumption of cruciferous vegetables (from the Brassicaceae plant family) is 
associated with a reduced risk of several cancers, particularly cancers of the stomach and 
lung (1-4).  Cruciferous vegetables contain high amounts of sulfur-containing compounds 
called glucosinolates (5) which, upon hydrolysis by the enzyme myrosinase, results in the 
formation of biologically active compounds such as indoles and isothiocyanates.  These 
compounds are hypothesized to play a role in chemoprevention, in part, through 
regulation of phase II conjugating enzymes, including UDP-glucuronosyl transferase 
(UGT) (3, 6-11). 
 
UGT are a superfamily of enzymes that catalyze the transfer of the glucuronyl 
group from uridine 5’-disphosphoglucuronic acid to endogenous molecules, as well as 
exogenous compounds, including therapeutic drugs and dietary carcinogens, to produce 
less toxic, more polar molecules that are more easily excreted (12).  UGT1A1, one of 
nine enzymes in the UGT1A family, conjugates bilirubin and estrogens (17β-estradiol 
and estriol),  as well as heterocyclic amines and polycyclic aromatic hydrocarbons (13).  
UGT1A1 is also the only UGT that preferentially conjugates bilirubin (14).   
 
Polymorphisms in the upstream promoter region of UGT1A1, characterized by 
variation in the number of thymine-adenine (TA) repeats, alter UGT1A1 transcriptional 
activity (14, 15).  Compared to 6 TA repeats (UGT1A1*1) found in the wild-type allele, 
the presence of 7 (UGT1A1*28) TA repeats has been shown to down-regulate 
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transcription and is the genetic basis for mild unconjugated hyperbilirubinemia associated 
with reduced hepatic UGT conjugation of bilirubin (i.e. Gilbert syndrome) (16). 
 
Glutathione S-transferases (GST) are also involved in the detoxification of a 
broad range of electrophiles by conjugation with glutathione (17).  Isothiocyanates in 
cruciferous vegetables are substrates for GST, particularly GSTM1 (18).  Null genotypes 
for GSTM1 and GSTT1 result in the absence of the respective enzymes; thus, among 
GSTM1-null and GSTT1-null individuals, isothiocyanates have been hypothesized to be 
metabolized more slowly, leading to greater accumulation of isothiocyanates at the tissue 
level and, therefore, possibly a greater chemoprotective effect (19). 
 
Previously, in an observational study, we found a positive association between 
intake of Cruciferae and UGT1A1 activity among individuals with the *28/*28 variant, 
but not *1/*28 or *1/*1 genotypes (12).  In a subsequent controlled feeding study, a 
mixed diet of crucifers, soy and citrus (all sources of UGT inducers (7, 8, 20-24)) 
compared to a fruit and vegetable-free diet resulted in increased UGT1A1 activity, but 
only in women with the *28/*28 genotype (25).  Our objectives in the present human 
feeding trial were to examine the effects of cruciferous vegetables specifically, on 
conjugation of bilirubin, as a measure of UGT1A1 activity, and to compare two different 
amounts to determine if response was dose-dependent.  In addition, we investigated 
whether GSTM1-null and GSTT1-null variants or the UGT1A1*28 polymorphism affect 
this response.  A secondary aim of the study was to evaluate whether the addition of 
apiaceous vegetables to cruciferous feeding further alters this response.
 6
Methods 
Research Design 
The project activities were conducted in the context of an existing study, 
“Enzyme Activation Trial 2” (2EAT), and carried out at Fred Hutchinson Cancer 
Research Center, Seattle (FHCRC), Washington.  The overall goal of the parent study 
was to evaluate the effect of plant foods from the Brassicaceae and Apiaceae families on 
activities of Phase I, (specifically CYP1A2) and Phase II, (specifically GST) conjugating 
enzymes, and the impact of genetic polymorphisms in biotransformation enzymes on the 
response to diet.  The focus of the work presented here builds on our previous findings of 
alterations in bilirubin concentrations (used as a surrogate measure of UGT1A1 enzyme 
activity) in response to cruciferous vegetable feeding and UGT1A1 genotype (12, 25).  
Recruitment, enrollment, feeding, sample collection, and laboratory analysis for this 
project took place from March, 2003 to July 2007.  The 2EAT study was a randomized, 
controlled, crossover feeding trial of four diets – basal (devoid of fruit and vegetables), 
two doses of cruciferous vegetables, and cruciferous plus apiaceous (carrot family) 
vegetables.  Participants were blocked on GSTM1/GSTT1 genotype-by-sex and assigned 
to the four controlled diets in a computer-generated random sequence.   
 
Study Participants 
Participants were healthy, non-smokers, aged 20-40 years, and were recruited on 
the basis of sex and CYP1A2, GSTM1, and GSTT1 genotypes.  Methods of recruitment 
included paid advertisements in campus newspapers and flyers posted on university 
campuses in Seattle, informational web site, and four targeted, bulk mailings using lists 
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obtained from the State of Washington, Department of Licensing.  Screening was 
conducted in two phases.  In the first phase, prospective participants were screened for 
eligibility using a self-administered questionnaire and were excluded if they reported any 
of the following:  medical history of gastrointestinal, hepatic, or renal disorders; 
pregnancy or lactation; known allergies/intolerances to any foods used in the feeding 
trial; weight change greater than 4.5 kg within the past year; major changes in eating 
habits within the past year (e.g. adoption of a faddish diet); antibiotic use within the past 
3 months; body weight greater than 150% of desirable; exercise patterns that require or 
result in major changes in diet;  current use of prescription medication (including oral 
contraceptives); current use of over-the-counter medications; regular exposure to passive 
smoke; occupational exposure to smoke or organic solvents; food dislikes that would 
preclude participation in the feeding trial; alcohol intake of > 2 drinks/day (2 drinks being 
equivalent to 720 mL beer, 240 mL wine, or 90 mL spirits); no interest in participating in 
a controlled feeding trial.   
 
In the second screening phase, eligible individuals were selected according to the 
genotypes of interest.  The goal of the parent study was to recruit 72 participants 
according to three groups of GST genotypes (GSTM1+/GSTT1+, GSTM1-null/GSTT1+, 
and GSTM1-null/GSTT1-null), and three CYP1A2(C734 A) genotypes (C/C, C/A, and A/A), 
with a ratio of 2:2:1 and an equal number of men and women in each group.  The 
CYP1A2(C734 A) genotypes were of interest in relation to other objectives, which were to 
investigate the genotypic effect on induction or inhibition of CYP1A2 activity in 
response to vegetable supplementation.  These findings will be reported elsewhere.    In 
 
 8
all, we randomized 72 individuals: (14 GSTM1+/GSTT1+ men, 12 GSTM1+/GSTT1+ 
women, 16 GSTM1-null/GSTT1+ men, 14 GSTM1-null/GSTT1+ women, 5 GSTM1-
null/GSTT1-null men, and 9 GSTM1-null/ GSTT1-null women, and 2 GSTM1+/GSTT1-
null women).  The two women with the GSTM1+/GSTT1-null genotypes were recruited 
for their CYP1A2 genotype, and were not included in this analysis.  Twelve participants 
dropped out of the study, four after the first feeding period, five after the second, and 
three after the third.  Data for all completed diet periods were included in the analysis, 
even if the participants did not complete all four diet periods.  Reasons for dropping out 
included work schedules that prevented travel to the Center, intolerance of study foods, 
illness, and a move out of the area.  As these individuals dropped out, new recruits were 
selected and randomized into the appropriate treatment orders to maintain the blocks.  
The Institutional Review Board at the Fred Hutchinson Cancer Research Center approved 
the study activities and informed written consent was obtained from all participants prior 
to the start of the study.   
 
Study Diets 
We measured usual dietary intake using 3-day records in order to assess habitual 
dietary intake at baseline and to determine energy needs.  Nutrient data were collected by 
the staff of the Nutrition Assessment Shared Resource (NASR) of FHCRC, using 
collection tools developed by NASR.  Nutrient calculations were performed using the 
Nutrient Data System for Research (NDSR) software version 4.05-33, developed by the 
Nutrition Coordinating Center, University of Minnesota, Minneapolis, MN, Food and 
Nutrient Database.  As part of the intervention, participants consumed four different 
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controlled diets:  (i) a basal diet devoid of fruit and vegetables; (ii) the basal diet 
supplemented with a prescribed amount of cruciferous vegetables (single-dose 
cruciferous diet); (iii) the basal diet supplemented with twice this amount of cruciferous 
vegetables (double-dose cruciferous diet); (iv) and the basal diet supplemented with 
cruciferous and apiaceous vegetables (single-dose cruciferous plus apiaceous vegetable 
diet) (TABLE 1).  For a 70 kg individual, the amount of vegetables provided was 
equivalent to approximately 5 servings a day for the single-dose cruciferous diet and 10 
servings for the double-dose cruciferous diet, and 7 for the cruciferous plus apiaceous 
diet, although the exact amounts were based on a per-kg-body-weight basis.  The single-
dose of cruciferous vegetables was approximately 7 g/kg body weight, the double dose 
was approximately 14 g/kg and the mixed diet included 7 g/kg of crucifers plus 4 g/kg 
apiaceous vegetables.  Diets were first standardized according to servings for a 70 kg 
individual, determining g food/kg body weight for each plant food item.  Vegetable 
amounts were then increased or decreased to the nearest 5 kg increment in body weight 
for individuals who weighed more or less than 70 kg.  We provided mixtures of 
vegetables within the botanical families rather than a single vegetable representing the 
family in order to better capture real-life exposure to a variety of vegetables.  Each of the 
four diet periods lasted 14 days with a 21-day washout period between diet periods.  
These feeding period lengths were chosen based on our previous study that showed 
serum GST-α protein concentrations were still increasing from day 6 to day 7 in response 
to cruciferous vegetable supplementation (26), despite reports that biotransformation 
enzymes are rapidly induced (27).   
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Participants were instructed to consume only the food and beverages provided for 
them during the diet periods and were requested not to take any type of medication, 
alcoholic beverages, or nutritional supplements and to maintain their usual physical 
activity during each feeding period.  Dinner was served at the FHCRC Human Nutrition 
Lab dining room Sunday through Friday evening, and food for the following day’s 
morning, midday meal, and snacks was distributed at that time.  On Friday evening, 
participants picked up food for all of Saturday and for Sunday daytime meals.  The major 
portion of the test vegetables was provided as part of the dinner, under the supervision of 
the study staff.  Any food not consumed was noted on the participant’s chart.  
Compliance with the study diet was also monitored using daily food check-off forms with 
space provided so that participants could record any deviations from the diet.  
 
Specimen collection 
Biological samples were collected prospectively from participants and during 
each two-week feeding period.  Buccal cells, collected prior to randomization, were 
isolated and DNA extracted for determination of GSTM1 and GSTT1 genotypes and 
participant eligibility.  Prospective participants were asked to collect their buccal cells by 
vigorously swishing 10 ml of undiluted, commercial mouthwash in their mouth for 60 
seconds.  They then expelled the solution into a collection container, sealed and returned 
the sample via US mail to the FHCRC Specimen Processing Laboratory, where DNA was 
extracted using the QIAamp DNA Blood Midi kit (Qiagen, Valencia, CA). 
 
 
 11
At day 0, 7, 11 and 14 of each feeding period, blood was drawn in the morning 
after a 12-hour overnight fast.  The multiple draws were selected to allow for monitoring 
changes in response to diet over the course of each feeding period.  Tubes without 
additive were allowed to clot at room temperature for 30 minutes before they were 
centrifuged to separate the serum.  Serum was aliquotted and stored at -80° C.  On day 0 
of the first feeding period, blood was also drawn into a tube containing EDTA for 
collection of white blood cell DNA (buffy coat).  On day 13 of each feeding period, 
participants collected urine for 24 hours.  All urine samples were refrigerated at 4° C until 
delivery in the morning (day 14) to FHCRC.  The total volume and pH value were 
recorded and the sample was aliquotted and stored at -80° C.    
 
GSTM1 and GSTT1 Genotyping  
GSTM1 and GSTT1 genotyping was conducted on buccal cell DNA using primers 
described by Arand, et al. (28).  β-globin was co-amplified to ensure that the GSTM1-null 
and GSTT1-null genotypes were due to the deletion of the GSTM1 or GSTT1 alleles and 
not to failure of the PCR.  Thermal cycling included an initial denaturation at 95°C for 2 
min, followed by 35 cycles of 94°C for 1 min, 60°C for 1 min, 72°C for 2 min and 1 
cycle of 72°C for 5 min.  Individuals homozygous or heterozygous for GSTM1 
phenotypes gave a 215-bp PCR fragment; GSTM1-null individuals did not. A 480 bp 
fragment was detected for individuals who carried at least one GSTT1 allele.  
 
UGT 1A1 Genotyping 
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The UGT1A1 polymorphism (UGT1A1*28) consists of 7 TA repeats in the 
promoter region, 6 TA repeats being the wild type (UGT1A1*1).  Genotyping of the 
white blood cell DNA for the UGT1A1 polymorphism was conducted as described 
previously (29).  
  
Bilirubin Analysis 
Serum total and direct (conjugated) bilirubin were measured using a Cobas MIRA 
Plus centrifugal analyzer (Roche Diagnostic Systems, Somerville, NJ), as described (29).   
Indirect (unconjugated) bilirubin is calculated by difference (total bilirubin – direct 
bilirubin).  Mean intra- and inter-assay CV variances were, respectively, 2.1 and 3.2% for 
total bilirubin, and 2.6 and 2.9% for direct bilirubin.   
 
Isothiocyanate excretion  
Twenty-four hour urines collected on day 13 were used to measure 
isothiocyanates for compliance purposes (25).  The assay for urinary total isothiocyanates 
was based on the HPLC-based method developed by Chung et al. (30), and measures 
dithiocarbamates (isothiocyanates plus glutathione-derived conjugates) as well as the 
synthesis of phenethyl isothiocyanates-N-acetyl conjugate (PEITC-NAC) used for 
standard calibrations. 
 
Statistical Analysis  
To make distributions more normal, a natural logarithmic transformation was 
performed on total, direct, and indirect bilirubin concentrations prior to analysis.  A linear 
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mixed model including sex, UGT1A1 genotype, feeding periods, diet treatments, feeding 
order, sampling day and interaction terms as fixed effects and participants as a random 
effect, and the observations at day 0 and habitual diet were covariates adjusted in the 
model.  Participants were blocked by GST genotype for diet-order randomization.  All 
statistical analyses were performed using the SAS Program (version 8.2; SAS Institute).  
Data are presented as back-transformed least squares (LS) –means + LS standard errors, 
unless otherwise indicated.  Two-sided P-value for statistical significance was set at 
<0.05.   
 
 To prevent confounding by body weight between the sexes, the amount of 
vegetables provided was based on a per-kg-body-weight calculation, and ranged from 
284g to 662g for the single-dose cruciferous diet, 568g to 1324g for the double-dose 
cruciferous diet, and 458g to 1065g for the single-dose plus apiaceous diet.  Analyses 
were conducted both with and without adjusting for vegetable amount; because there 
were no statistically significant differences between the analyses with and without 
adjustment, the data are presented without adjustment.   
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Results 
Of the 70 participants in the study, 58 completed all 4 diet periods, 8 completed 2 
or more and 4 completed 1.  The distribution of UGT1A1 genotypes in the study 
population was 41% (n=29) and 51% (n=36) for *1/*1 and *1/*28 respectively, and 7% 
(n=5) for *28/*28.  There were no statistically significant differences in the demographic 
and baseline characteristics of the 70 individuals by UGT1A1 genotype (TABLE 2).  As 
expected, serum total, direct and indirect bilirubin concentrations for participants 
consuming their habitual diets were statistically significantly higher among those with the 
UGT1A1*28/*28 genotype (P < 0.02 for all 3 bilirubin measures). 
 
 Aggregate (all individuals, irrespective of genotype, and days 7, 11 and 14 
combined) LS mean ± LS-SE total bilirubin concentrations for individuals on basal, 
single-dose cruciferous, double-dose cruciferous and cruciferous plus apiaceous diets 
were 16.07 ± 1.27,  15.39 ± 1.37, 14.71 ± 1.20 and 14.88 ± 1.20 µmol/L respectively.  
Response to all 3 vegetable-containing diets differed statistically significantly from the 
basal diet, with lower mean total bilirubin concentrations associated with consumption of 
the vegetable test diets (P < 0.02 for all 3), suggesting greater UGT1A1 enzyme activity.  
Individual diet contrasts showed statistically significantly lower mean bilirubin 
concentrations on the double-dose cruciferous diet compared to the single-dose 
cruciferous diet, suggesting a dose-response, (P = 0.03) and a tendency toward lower 
bilirubin concentrations on the cruciferous plus apiaceous diet compared to the single-
dose cruciferous diet (P = 0.08).  Response to double-dose cruciferous and cruciferous 
plus apiaceous diets was similar (P = 0.7).  Results for unconjugated bilirubin 
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concentrations paralleled those of total bilirubin; however, the low values for conjugated 
bilirubin concentrations did not differ by diet (data not shown).  The interaction term of 
diet-by-sex was not statistically significant, and although men tended to have higher total 
bilirubin concentrations on all diets, this also was not significant (P = 0.75).   
 
UGT1A1*28 Genotype Effects 
Overall, total mean bilirubin concentrations differed by UGT1A1 genotype (P = 
0.049).  Individuals with the *28/*28 variant had approximately 27% overall higher 
bilirubin concentrations compared to those with *1/*1 (P = 0.02) and 19% higher 
concentrations compared to those with *1/*28 (P = 0.07).  The difference between 
individuals with *1/*1 and *28/*28 was particularly apparent on the basal and single-
dose cruciferous vegetable diets, where overall difference in values were 40% and 27% 
higher respectively (P < 0.01 for basal and 0.03 for single-dose cruciferous) (TABLE 3).  
Although this difference was still evident within the double-dose cruciferous (22%) and 
cruciferous plus apiaceous diets (18%), it was no longer statistically significant (P = 0.07 
and 0.15 respectively).  The differences between *1/*1 and *1/*28 were smaller and 
statistically significant only on the single-dose cruciferous diet, with *1/*28 having 10% 
higher bilirubin concentrations than *1/*1 (P = 0.02).   
 
Response to diet also tended to differ by genotype, although the formal interaction 
term of diet by UGT genotype on total bilirubin concentrations was not statistically 
significant (P = 0.13).  Within *28/*28 individuals, serum bilirubin concentrations were 
16-21% lower on all three vegetable-supplemented diets than on the basal diet (P < 0.02 
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for all 3).  In contrast, within *1/*1 individuals, bilirubin concentrations were only about 
7% lower for both single and double-dose cruciferous diets compared to the basal diet (P 
< 0.03 for both) and there was no effect of the cruciferous plus apiaceous diet compared 
to basal.  Within *1/*28 individuals, bilirubin concentrations were approximately 6% 
lower for double-dose cruciferous diet (P = 0.02) and 8% lower for the cruciferous plus 
apiaceous diet (P = 0.002).  There was no effect of the single-dose cruciferous diet within 
*1/*28.  When comparing differences in response to diets between groups, *28/*28 
individuals responded marginally greater to the single-dose cruciferous diet compared to 
*1/*28 individuals (P = .049), and statistically significantly greater to the cruciferous plus 
apiaceous diet (P = 0.03). 
 
GSTM1/GSTT1 Genotype Effects: 
 GST enzymes metabolize isothiocyanates.  Because variation in GST activity may 
influence isothiocyanate exposure, we also tested the effect of GSTM1 and GSTT1 
genotypes on response to diet.  There was not a statistically significant main effect of the 
combined GSTM1 and GSTT1 genotypes (P = 0.48) or the interaction of genotype-by-diet 
(P = 0.54).  Although evaluation of the effects of diet stratified by genotype revealed 
some statistically significant genotypic differences, the magnitude was similar and not 
statistically significant between genotypes (TABLE 4).  For example, individuals who 
were GSTM1-null/GSTT1+ had about 7% lower bilirubin concentrations on both the 
single-dose and double-dose cruciferous vegetable diets compared to the basal diet (P < 
0.01 for both) and a 10% decrease on the cruciferous plus apiaceous vegetable diet (P < 
0.01).  GSTM1-null/GSTT1-null individuals had 5% lower bilirubin concentrations on the 
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single-dose cruciferous diet (P = 0.19), a 12% decrease on the double-dose cruciferous 
diet (P = 0.01) and a 10% decrease on the cruciferous plus apiaceous vegetable diet (P 
=0.07) compared to the basal diet.  GSTM1+/GSTT1+ individuals did not respond to the 
single-dose cruciferous vegetable diet, but had approximately 7% lower bilirubin 
concentrations on the double-dose cruciferous and cruciferous plus apiaceous diets (P 
=0.01 and 0.02, respectively). 
 
 Twenty-four hour urinary analysis of isothiocyanate metabolite excretion, 
collected on day 13 was measured for compliance.  Mean ± SD total isothiocyanate 
concentrations for the basal, single-dose cruciferous, double-dose cruciferous and 
cruciferous plus apiaceous diets were 2.14 ± 2.53, 112.51 ± 63.08, 257.76 ± 172.17, and 
105.90 ± 66.26 µmol/24 hours, respectively, indicating a steep, and dose-dependent 
increase in isothiocyanate excretion over the basal diet period.  93% of the study 
vegetables were consumed on the single-dose cruciferous vegetable diet, 87% on the 
double-dose cruciferous diet and 89% on the cruciferous plus apiaceous diet.  Based on 
the daily food check-off forms, participants consumed non-study food items fewer than 
3% of the study days. 
 
In order to evaluate the effect of the length of intervention on serum bilirubin, we 
measured serum bilirubin on days 0, 7, 11, and 14 of each feeding period.  There was a 
statistically significant effect of day of sampling (p<0.001), but the interaction of day-by-
diet was not statistically significant (p=0.28).  With vegetable supplementation, serum 
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bilirubin concentrations were lower on days 11 and 14 compared to day 7 (p<0.01) but 
bilirubin concentrations increased slightly from days 11 to 14 (p=0.04). 
 
 Because participants were selected in order to enrich for the CYP1A2*1F 
genotype in the parent study, analyses were carried out to evaluate whether this genotype 
was associated with changes in bilirubin.  The relationship between CYP1A2*1F and 
bilirubin was not statistically significant (data not shown). 
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Discussion 
In this study, serum bilirubin concentrations decreased in response to all three 
vegetable-containing diets compared to the fruit- and vegetable-free basal diet, 
underscoring the capacity of cruciferous vegetable consumption to modulate UGT1A1 
enzyme activity in vivo.  This response was particularly prominent among individuals 
with the *28/*28 genotype.  Mean total bilirubin concentrations for the single-dose 
cruciferous diet fell between the values for the basal diet and the double-dose cruciferous 
vegetable diet, suggesting a dose-response. 
 
Our results support the hypothesis that feeding cruciferous vegetables increases 
UGT1A1 activity.  A variety of dietary components, including isothiocyanates, have been 
shown to induce UGT activity in general, in animals (21, 31) and humans (32, 33); 
however, the substrates used to test for UGT activity have not been specific for UGT1A1.  
Recently, Gasper and colleagues (34) examined the expression of xenobiotic 
metabolizing enzymes in gastric mucosa in 4 individuals, 6 hours after consumption of a 
single meal of 100 g of broccoli or high-glucosinolate broccoli.  Induction of several 
metabolizing enzymes was observed with high-glucosinolate broccoli, but not the 
standard broccoli meal, and UGT was not among the enzymes that were induced.  Most 
in vitro evidence suggests that up-regulation of phase II enzymes by isothiocyanates 
occurs through interaction of the isothiocyanates with the cytoplasmic-anchoring protein 
Kelch-like ECH-associated protein 1 (Keap1) and the transcription factor Erythroid-
derived 2-like 2 (Nfe2l2, official nomenclature for the more commonly used Nrf2), via 
the antioxidant response element (ARE) (3, 6-11).  UGT1A1 has an ARE (9) as well as a 
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xenobiotics response element (XRE) in the promoter region (35-37).  Thus, the indoles in 
cruciferous vegetables, which induce phase I and II enzymes through binding to the AhR 
and interacting with the XRE, may also induce UGT1A1 expression.  Cruciferous 
vegetables contain a mixture of isothiocyanates and indoles; thus, it is possible that both 
contributed to increased UGT1A1 enzyme activity, and lower serum bilirubin in our 
study. 
 
The combination of single-dose cruciferous and apiaceous vegetables resulted in a 
reduction in bilirubin concentrations similar to that seen with the double-dose cruciferous 
vegetable diet.  This suggests that constituents in apiaceous vegetables may also increase 
UGT1A1 activity.  Apiaceous vegetables (i.e., carrots, dill, parsley, parsnips,  and celery 
in our study) are rich sources of furanocoumarins (e.g., psoralens, methoxypsoralen) (38).  
Effects of these specific apiaceous vegetable constituents on UGT1A1 induction have not 
been evaluated; however, Diawara et al. (39) showed that psoralens induced mRNAs of 
hepatic enzymes that are typically induced by compounds that interact with the AhR, and 
subsequently, the XRE (e.g., indoles).  In addition to furanocoumarins, some plants in the 
Apiaceae family contain the flavonoid apigenin.  Apigenin has been shown to induce 
UGT1A1 transcription in vitro (8, 40).  These data support our current findings and offer 
a plausible explanation for our results.  Finally, other enhancer element motifs have been 
identified in UGT1A1, including a PXRE (41).  Ruhl, et. al demonstrated PXR-mediated 
induction activity in PXR-responsive CYP450 genes by β-carotene in HepG2 cells (42).  
As carrots were included in our apiaceous diet protocol, we cannot rule out the possibility 
of modulation of UGT1A1 by β-carotene as an additional factor. 
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The presence of an additional TA repeat in the UGT1A1 promoter region has been 
shown to reduce transcription of this gene by as much as 50% among homozygous 
variants (14, 15).  In our study, as expected, a statistically significant phenotypic 
difference was observed between *1/*1 and *28/*28 UGT1A1 genotypes, with *28/*28 
individuals having approximately 27% overall higher total bilirubin concentrations than 
*1/*1 individuals.  Moreover, there were differences in diet response among the UGT1A1 
genotypes: among *1/*1 and *1/*28 individuals, there was a modest reduction (1-8%) in 
bilirubin in response to the single-dose and double-dose cruciferous diets, whereas 
statistically significant decreases in bilirubin concentrations were achieved on both the 
single-dose and double-dose cruciferous vegetable diets among *28/*28 individuals, and 
the magnitude of change was much larger (16-21%).  These results, along with our 
previous findings in an observational study and controlled fruit-and-vegetable feeding 
trial (12, 25), suggest that there may be a greater capacity for up-regulation of UGT1A1 
among individuals with the *28/*28 genotype.   
 
In this study, decreases in serum bilirubin were observed in response to 
cruciferous vegetable feeding in both men and women.  In contrast, in our previous 
controlled feeding trial, which included a mixed diet of crucifers, soy and citrus, the 
intervention effects on UGT1A1 activity were limited to women within the *28/*28 
genotype (25).  Several differences between the two studies may contribute to these 
observations.  The dose of crucifers in the previous study was 2.7 g/kg body weight 
compared to 7 and 14 g/kg provided in the present study.  Additionally, we used a mix of 
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foods from several botanical families in the previous study, (i.e., crucifers, citrus, and 
soy), whereas the focus was on crucifers in the present study.  It may be that the higher 
isothiocyanate doses are needed to elicit an effect in men and in individuals without the 
*28/*28 genotype, or that the inclusion of other phytochemicals attenuated the response 
to crucifers. 
 
Given that isothiocyanates are substrates for GST, (18) and also induce UGT and 
other enzyme systems, we hypothesized that the greatest difference in serum bilirubin 
concentrations in response to diet would occur in GSTM1-null/GSTT1-null individuals, 
followed by GSTM1-null/GSTT1+ and GSTM1+/GSTT1+.  Compared to 
GSTM1+/GSTT1+ individuals, GSTM1-null/GSTT1-null individuals had slightly greater 
decreases in bilirubin with cruciferous vegetable supplementation; but this response was 
not statistically significant, and slight decreases in bilirubin concentrations were observed 
in GSTM1-null genotypes, regardless of GSTT1 genotype.  Few studies have evaluated 
the capacity of GST genotype to modulate the effect of cruciferous vegetable intake on 
biomarkers in intervention trials.  We showed previously that the GSTM1-null, compared 
to GSTM1+ genotype, resulted in greater increases in serum GST-α concentrations in 
response to a 7-day cruciferous vegetable feeding intervention (26).  In both of these 
studies, the circulating biomarkers measured reflect hepatic enzyme activity.  In contrast, 
Traka, et al., (43) recently reported GSTM1 genotype-related changes in transforming 
growth factor beta 1 (TGFβ1) and epidermal growth factor (EGF) signaling pathways in 
prostate tissue after men consumed 400 g broccoli/week for 6 months.  GSTM1+ 
individuals showed greater diet-induced changes in prostate tissue gene expression.  In 
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order to further characterize the modifying effects of GST genotypes, future cruciferous 
vegetable interventions should be designed to include testing of the effects of these 
genotypes on biologic responses.   
 
A strength of our study is the controlled feeding-study design with the focus on a 
botanical family of vegetables tested in two different doses.  Additional strengths include 
the two-week duration of each study diet, the blood sampling at three time-points during 
each feeding period, and dosing based on participant body weight.  Overall, total bilirubin 
concentrations decreased until day 11 and then increased slightly from day 11 to day 14, 
suggesting that we achieved the maximal reduction in bilirubin with our vegetable 
treatments.  Further, the stringent inclusion criteria minimized potential confounding due 
to other factors that may influence UGT activity (e.g., age, BMI, and alcohol, tobacco, or 
medication use.) 
 
A primary limitation of the study is our use of serum bilirubin concentrations as 
an indirect measure of UGT1A1 activity.  The actual change in hepatic enzyme activity 
in response to vegetable feeding may be greater than what we are able to measure 
indirectly using circulating bilirubin.  Another limitation was that this was an ancillary 
study.  Consequently, the number of individuals with the *28/*28 genotype was small 
and the study was not statistically powered to examine a priori effects of cruciferous 
vegetable-consumption on UGT1A1 enzyme activity.  Nonetheless, within the context of 
the parent study, we estimated that we would need a sample size of 5 individuals with the 
UGT1A1*28 genotype to detect, with 80% power, a 15% difference in total bilirubin 
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concentrations from the basal diet.  Although we achieved this sample size, the small 
number of individuals with the *28/*28 genotype did not allow for formal statistical 
evaluation of the diet-by-sex-by-genotype interactions.  Another potential limitation is 
generalizability.  The average intake of cruciferous vegetables in the U.S. is about 25-30 
g per day (2).  Although the cruciferous vegetables used in our study, i.e., broccoli, 
cauliflower, and cabbage are some of the most commonly consumed vegetables in the 
U.S. diet, they are not usually consumed in the relatively large amounts we gave in this 
study (e.g., 5-10 servings per day or ~300g – 1300g.)  Additionally, while radishes are 
commonly consumed, radish sprouts, part of our diet protocol, are not. 
 
In summary, cruciferous vegetable supplementation lowered bilirubin 
concentrations in a dose-dependant manner.  Although UGT1A1 activity, as measured by 
serum bilirubin, was greater in GSTM1-null individuals compared to GSTM1+ 
individuals, this response was not statistically significant.  Differences in bilirubin 
concentrations occurred with a lower cruciferous dose and to a greater extent within 
*28/*28 individuals compared to those with one or more *1 allele.  Given the reduced 
transcriptional activity of UGT1A1 in individuals with 7 or more TA repeats (i.e., *28) 
(16) and the role of this enzyme in the conjugation of estrogens and carcinogens, such as 
heterocyclic amine metabolites (12, 44),  improving glucuronidation may be beneficial in 
this subset of individuals.  Finally, our results in humans agree with the in vitro and 
experimental animal model data that suggest that constituents of apiaceous vegetables 
may also modulate UGT1A1.   
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TABLE 1  Amounts of vegetables fed on each vegetable-containing test diet calculated 
for an individual at the reference weight of 70 kg body weight (BW).   
 
 
        Dietary Constituents                            g/70 kg BW      g/5kg BW‡  
 
Single-dose Cruciferous Diet 
Frozen broccoli*                                203                   15 
Frozen cauliflower*                                            152                   11 
Fresh red cabbage†                                                     36                    3 
Fresh green cabbage†                                                 36                    3 
Fresh radish sprouts§                             16                    1 
 
Double-dose Cruciferous Diet 
Frozen broccoli                                  406                  29 
Frozen cauliflower                                             305                  22 
Fresh red cabbage                                                       71                     5 
Fresh green cabbage                                                    71                   5 
Fresh radish sprouts                                         32                    2 
 
 
Cruciferous + Apiaceous Diet 
Frozen broccoli                                  203                  15 
Frozen cauliflower                                        152                  11 
Fresh red cabbage                                                       36                     3 
Fresh green cabbage                                                  36                      3 
Fresh radish sprouts                             16                     1 
Frozen carrots*                                                        111                     8 
Fresh parsnips†                                              102                     8 
Fresh celery†                                   50                     4 
Fresh parsley†                                                   5                  0.4 
Fresh dill weed†                                  0.7                 0.05 
‡ Vegetable amounts were increased or decreased to the nearest 5 kg increment in BW 
for individuals who weighed more or less than 70 kg.  These foods supplemented a basal 
diet that was otherwise devoid of fruits and vegetables.  
*Norpac foods, Lake Oswego, OR 
†Food Service of America, Seattle, WA 
§Uwajimaya’s, Seattle, WA 
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TABLE 2  Characteristics of study participants by UGT1A1 genotype 
 
     UGT1A1 *1/*1  UGT1A1 *1/*28  UGT1A1 *28/*28 P valuea 
         n=29 (41%)     n=36 (51%)          n=5 (7%) 
Age (yr)                   32 ± 7.16b       33 ± 5.50   31 ± 6.02  0.74 
 
Height (m)    1.7 ± 0.11   1.7 ± 0.09   1.7 ± 0.14  0.79 
 
Weight (kg)    71.0 ± 15.96   68.4 ± 13.86   72.74 ± 12.37  0.93 
 
BMI (kg/m²)    20.7 ± 3.8   20.1 ± 3.3   24.4 ± 2.4  0.98 
 
Female (%)                  45% (13)    55% (20)   60% (3)  0.64 
 
Race (%) 
     Caucasian         48% (14)      72% (26)    60% (3)  0.08 
     Asian         48% (14)     17% (6)     40% (2) 
     Other*         0.03% (1)     0.11% (4)    0 
 
GSTT1/GSTM1 genotype             0.96 
     (+/+) (46% female)          12             12           2    
     (-/+) (50% female)                      11              17           2    
     (-/-)  (64% female)              6                7           1     
 
Serum Bilirubinc (µmol/L) 
     Total      14.02 ± 4.96    14.02 ± 4.79           25.31 ± 9.75  0.01 
     Direct       1.88 ± 0.68      1.88 ± 0.51             3.25 ± 1.03  0.01 
     Indirect      12.14 ± 4.45    12.14 ± 4.45           22.06 ± 8.89  0.02 
a  Tests for a trend across UGT1A1 genotypes (χ2)   
b Mean ± SD  
c When consuming habitual diets 
*Other includes African Americans and Pacific Islanders 
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TABLE 3   Serum total bilirubin concentrations in participants stratified by UGT1A1 
genotype, diet period, and day of sampling 
 
 
                             Total Bilirubin (µmol/L) 
 
                                   Basal                Single-dose          Double-dose         Cruciferous  
                                                           Cruciferous          Cruciferous        plus Apiaceous 
 
UGT1A1 *1/*1 (n=29) 
 
Day 7                    14.88 ± 1.54*a      13.85 ± 1.37a          14.88 ± 1.37a          15.05 ± 1.37a 
Day 11                  15.05 ± 1.54a          14.19 ± 1.37ab         13.34 ± 1.20b          14.02 ± 1.37ab 
Day 14                  15.73 ± 1.54a             14.36 ± 1.37b           14.02 ± 1.37b          14.02 ± 1.37b 
 
Mean†                   15.22 ± 1.37a          14.19 ± 1.37b          14.19 ± 1.20b         14.36 ± 1.37ab 
 
 
UGT1A1 *1/*28 (n=36) 
 
Day 7                    16.59 ± 1.54a          16.59 ± 1.54a            15.90 ± 1.54a          15.73 ± 1.54a 
Day 11                  15.90 ± 1.54a           15.56 ± 1.54a b        14.36 ± 1.54bc          14.19 ± 1.37c 
Day 14                  15.90 ± 1.54a          15.56 ± 1.54ab         15.05 ± 1.37ab          14.31 ± 1.37b 
 
Mean                     16.07 ± 1.54a         15.90 ± 1.54ac         15.05 ± 1.37bc         14.71 ± 1.37b 
 
 
UGT1A1 *28/*28 (n=5) 
 
Day 7                    21.72 ± 3.25a         19.32 ± 2.91ab         16.59 ± 2.57b          18.13 ± 2.74ab 
Day 11                  20.35 ± 3.08a         18.81 ± 2.74ab         17.78 ± 2.74ab         15.39 ± 2.22b 
Day 14                  22.06 ± 3.25a         16.07 ± 2.39b           17.44 ± 2.74ab         17.27 ± 2.57b 
 
Mean                     21.38 ± 2.91a         17.96 ± 2.39b          17.27 ± 2.39b          16.93 ± 2.39b 
 
*LS back-transformed means ± LS SE, adjusted for sex, baseline and day 0 bilirubin concentrations.   
a, b and c: Diet means within a row not sharing a common superscript are significantly different as 
tested by ratio of means; p<0.05 
†Mean of 3 sampling days (7, 11, and 14)
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TABLE 4  Mean serum total bilirubin concentrations in participants stratified by GSTM1/T1 
genotype and diet period 
 
 
                                       Total Bilirubin (µmol/L)  
 
                                                    Basal             Single-dose         Double-dose       Cruciferous  
         Cruciferous        Cruciferous      plus Apiaceous 
 
GSTM1+/GSTT1+               15.39 ± 1.37*ac    15.05 ± 1.37ac      14.19 ± 1.20b       14.36 ± 1.20bc 
    (n=26)      
 
 
GSTM1-null/GSTT1+         15.90 ± 1.54a       14.88 ± 1.37b       14.88 ± 1.37b         14.36 ± 1.37b 
         (n=30) 
 
 
GSTM1-null/GSTT1-null    17.10 ± 1.71a       16.07 ± 1.54 ab      14.88 ± 1.54b        15.56 ± 1.54ab 
    (n=14) 
 
*Back-transformed LS means ± LS SE, adjusted for sex, diet order, and habitual and day 0 bilirubin 
concentrations 
Means not sharing common superscript within a genotype are significantly different as tested by ratio of 
means; p<0.05 
 
 
 
 
 
 
 
 
 
